CONKLING WILLIAM (CIK 1852018) reported 8 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-11). Recent activity: Buy IDT (673 shares), Sell TARA (6,008 shares), Buy TARA (26,000 shares), Buy TARA (50,000 shares), Buy RFL (27,454 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | IDT CORP (IDT) | Director | Buy | 673 | $37,520 |
| 2026-06-03 | Protara Therapeutics, Inc. (TARA) | Chief Commercial Officer | Sell | 6,008 | $26,075 |
| 2026-01-21 | Protara Therapeutics, Inc. (TARA) | Chief Commercial Officer | Buy | 26,000 | $0 |
| 2025-06-04 | Protara Therapeutics, Inc. (TARA) | Chief Commercial Officer | Buy | 50,000 | $0 |
| 2025-04-24 | Rafael Holdings, Inc. (RFL) | Chief Executive Officer | Buy | 27,454 | $0 |
| 2025-03-25 | Rafael Holdings, Inc. (RFL) | Chief Executive Officer | Sell | 14,814 | $28,591 |
| 2025-03-03 | Cyclo Therapeutics, Inc. (CYTH) | Director | Buy | 27,654 | $0 |
| 2025-01-15 | Rafael Holdings, Inc. (RFL) | Chief Executive Officer | Buy | 60,000 | $117,000 |
Source: SEC Form 4 filings · as of 2026-06-11